Support the psilocybin depression study led by Principal Investigator Prof. Dr. Gerhard Gründer at ZI Mannheim in collaboration with the Charité Universitätsmedizin Berlin, which will pave the way for future phase III studies and regulatory approval of this drug for standard treatment.
Funding psychedelic research could unlock innovative treatments for the millions of people who suffer from mental health disorders like depression and anxiety.
Please contact Sasha Silberberg for any questions regarding donations.
5% of your donation will also help us cover administrative fees.
כתובת אימייל *